Does OLANZAPINE Cause Poor venous access? 6 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Poor venous access have been filed in association with OLANZAPINE (Olanzapine). This represents 0.0% of all adverse event reports for OLANZAPINE.
6
Reports of Poor venous access with OLANZAPINE
0.0%
of all OLANZAPINE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Poor venous access From OLANZAPINE?
Of the 6 reports, 5 (83.3%) required hospitalization.
Is Poor venous access Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLANZAPINE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does OLANZAPINE Cause?
Drug ineffective (5,139)
Weight increased (3,588)
Off label use (3,256)
Toxicity to various agents (3,175)
Somnolence (2,612)
Sedation (2,130)
Suicide attempt (2,116)
Confusional state (1,898)
Condition aggravated (1,810)
Overdose (1,765)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
ECULIZUMAB (555)
HUMAN IMMUNOGLOBULIN G (504)
NATALIZUMAB (422)
RITUXIMAB (299)
TOCILIZUMAB (287)
METHOTREXATE (257)
ABATACEPT (249)
Which OLANZAPINE Alternatives Have Lower Poor venous access Risk?
OLANZAPINE vs OLANZAPINE\SAMIDORPHAN L-MALATE
OLANZAPINE vs OLAPARIB
OLANZAPINE vs OLARATUMAB
OLANZAPINE vs OLECLUMAB
OLANZAPINE vs OLIVE OIL\SOYBEAN OIL